Peptide Therapeutics Market Scope And Analysis

Peptide Therapeutics Market Report Scope

Peptide Therapeutics Market News and Recent Developments

The peptide therapeutics market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. The following is a list of developments in the market for peptide therapeutics:

• Novo Nordisk announced that the U.S. Food and Drug Administration (FDA) approved an additional indication for Wegovy to reduce the risk of major cardiovascular events such as death, heart attack, or stroke in adults with known heart disease and with either obesity or overweight along with a reduced calorie diet and increased physical activity. (Novo Nordisk A/S, Press Release, 2024)
• Ono Pharmaceutical Co., Ltd. announced that it entered into a drug discovery collaboration agreement with PeptiDream Inc., to discover and develop novel macrocyclic constrained peptide drugs against multiple targets. Under the terms of the agreement, PeptiDream will identify and optimize macrocyclic constrained peptide drug candidates for multiple targets of interest selected by Ono, by using PeptiDream’s proprietary Peptide Discovery Platform System (PDPS) technology. (Source: ONO PHARMACEUTICAL CO., LTD., News, 2023)
• Biosynth, a supplier of critical materials to the life science industry, announced the acquisition of Pepceuticals, a UK producer of synthetic peptides with multi-kilogram GMP facilities and fill-finish capabilities designed to support customers from clinical trials to commercial supply. The acquisition enables the support of all phases of the product life cycle from discovery to commercialisation. (Source: Biosynth, News, 2023)
• IRBM, an innovative contract research organization, announced that it has signed a new agreement with Merck & Co. Inc., to continue their collaboration in the peptide therapeutics area. The collaboration allows to combine IRBM’s first-class scientific expertise in peptide design and synthesis with Merck & Co. Inc.’s exceptional drug development capabilities with a focus on delivering innovative therapies to patients in need. (Source: IRBM S.p.A.; Press Release; 2023)
• Hokkaido University researchers have developed a novel method to design and develop peptide antibiotics in large numbers, which will prove critical to controlling antibiotic resistance. (Hokkaido University, Press Release, 2023)

Peptide Therapeutics Market Report Coverage and Deliverables

The “Peptide Therapeutics Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:

• Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
• Market dynamics such as drivers, restraints, and key opportunities
• Key future trends
• Detailed PEST/Porter’s Five Forces and SWOT analysis
• Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
• Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments
• Detailed company profiles